MACC1 facilitates the escape of nasopharyngeal carcinoma cells from killing by natural killer cells

References

• Feng M, Huang Y, Fan X, et al. Prognostic variables for temporal lobe injury after intensity modulated-radiotherapy of nasopharyngeal carcinoma. Cancer Med. 2018;7:557–564.
   PubMed Web of Science ®Google Scholar
• Zhou M, Zhou G, Hu S, et al. Tanshinone IIA suppress the proliferation of HNE-1 nasopharyngeal carcinoma an in vitro study. Saudi J Biol Sci. 2018;25:267–272.
   PubMed Web of Science ®Google Scholar
• He J, Xu J, Wu P, et al. Rapid detection of quantum dot immune chromatography nasopharyngeal carcinoma EBNA1 antibody. Oncol Lett. 2018;15:3562–3565.
   PubMed Web of Science ®Google Scholar
• Wu JH, Tang JM, Li J, et al. Upregulation of SOX2-activated lncRNA ANRIL promotes nasopharyngeal carcinoma cell growth. Sci Rep. 2018;8:3333.
   PubMed Web of Science ®Google Scholar
• Chan SL, Ng LS, Goh X, et al. Time course and clinical characterization of cisplatin-induced ototoxicity after treatment for nasopharyngeal carcinoma in a South East Asian population. Head Neck. 2018;40:1425–1433.
   PubMed Web of Science ®Google Scholar
• Stein U, Walther W, Arlt F, et al. MACC1, a newly identified key regulator of HGF-MET signaling, predicts colon cancer metastasis. Nat Med. 2009;15:59–67.
   PubMed Web of Science ®Google Scholar
• Stein U, Smith J, Walther W, et al. MACC1 controls Met: what a difference an Sp1 site makes. Cell Cycle. 2009;8:2467–2469.
   PubMed Web of Science ®Google Scholar
• Qian LQ, Li XQ, Ye PH, et al. Downregulation of MACC1 inhibits the viability, invasion and migration and induces apoptosis in esophageal carcinoma cells through the phosphatase and tensin homolog/phosphoinositide 3-kinase/protein kinase B signaling pathway. Oncol Lett. 2017;14:4897–4905.
   PubMed Web of Science ®Google Scholar
• Wang J, Wang W, Cai H, et al. MACC1 facilitates chemoresistance and cancer stem celllike properties of colon cancer cells through the PI3K/AKT signaling pathway. Mol Med Rep. 2017;16:8747–8754.
   PubMed Web of Science ®Google Scholar
• Wu J, Zhang D, Li J, et al. MACC1 induces autophagy to regulate proliferation, apoptosis, migration and invasion of squamous cell carcinoma. Oncol Rep. 2017;38:2369–2377.
   PubMed Web of Science ®Google Scholar
• Rohr UP, Herrmann P, Ilm K, et al. Prognostic value of MACC1 and proficient mismatch repair status for recurrence risk prediction in stage II colon cancer patients: the BIOGRID studies. Ann Oncol. 2017;28:1869–1875.
   PubMed Web of Science ®Google Scholar
• Meng F, Li H, Shi H, et al. MACC1 down-regulation inhibits proliferation and tumourigenicity of nasopharyngeal carcinoma cells through Akt/beta-catenin signaling pathway. PLoS One. 2013;8:e60821.
   PubMed Web of Science ®Google Scholar
• Hong Y, Zhao XY, Yu XX, et al. The impact of donor characteristics on the invariant natural killer T cells of granulocyte-colony-stimulating factor-mobilized marrow grafts and peripheral blood grafts. Transpl Immunol. 2018;48:55–59.
   PubMed Web of Science ®Google Scholar
• Burrello C, Garavaglia F, Cribiu FM, et al. Short-term oral antibiotics treatment promotes inflammatory activation of colonic invariant natural killer T and conventional CD4(+) T Cells. Front Med (Lausanne). 2018;5:21.
   PubMed Web of Science ®Google Scholar
• Rebuli ME, Pawlak EA, Walsh D, et al. Distinguishing human peripheral blood NK cells from CD56dimCD16dimCD69 + CD103+ resident nasal mucosal lavage fluid cells. Sci Rep. 2018;8:3394.
   PubMed Web of Science ®Google Scholar
• Glasner A, Levi A, Enk J, et al. NKp46 receptor-mediated interferon-gamma production by natural killer cells increases fibronectin 1 to alter tumor architecture and control metastasis. Immunity. 2018;48:396–398.
   PubMed Web of Science ®Google Scholar
• Vari F, Arpon D, Keane C, et al. Immune evasion via PD-1/PD-L1 on NK cells and monocyte/macrophages is more prominent in Hodgkin lymphoma than DLBCL. Blood. 2018;131:1809–1819.
   PubMed Web of Science ®Google Scholar
• Dabitao D, Hedrich CM, Wang F, et al. Cell-specific requirements for STAT proteins and Type I IFN receptor signaling discretely regulate IL-24 and IL-10 expression in NK Cells and macrophages. J Immunol. 2018;200:2154–2164.
   PubMed Web of Science ®Google Scholar
• Ko A, Han SY, Choi CH, et al. Oncogene-induced senescence mediated by c-Myc requires USP10 dependent deubiquitination and stabilization of p14ARF. Cell Death Differ. 2018; 25:1050–1062.
   PubMed Web of Science ®Google Scholar
• Wu J, Hann SS. Functions and roles of long-non-coding RNAS in human nasopharyngeal carcinoma. Cell Physiol Biochem. 2018;45:1191–1204.
   PubMed Web of Science ®Google Scholar
• Yoshizaki T, Kondo S, Endo K, et al. Modulation of the tumor microenvironment by Epstein-Barr virus latent membrane protein 1 in nasopharyngeal carcinoma. Cancer Sci. 2018;109:272–278.
   PubMed Web of Science ®Google Scholar
• Shibahara I, Hanihara M, Watanabe T, et al. Tumor microenvironment after biodegradable BCNU wafer implantation: special consideration of immune system. J Neurooncol. 2018;137:417–427.
   PubMed Web of Science ®Google Scholar
• Ravi R, Noonan KA, Pham V, et al. Bifunctional immune checkpoint-targeted antibody-ligand traps that simultaneously disable TGFβ enhance the efficacy of cancer immunotherapy. Nat Commun. 2018;9:741.
   PubMed Web of Science ®Google Scholar
• Wang N, Zhang Y, Liang H. microRNA-598 inhibits cell proliferation and invasion of glioblastoma by directly targeting metastasis associated in colon cancer-1. Oncol Res. 2018; 26:1275–1283.
   PubMed Web of Science ®Google Scholar
• Juneja M, Kobelt D, Walther W, et al. Statin and rottlerin small-molecule inhibitors restrict colon cancer progression and metastasis via MACC1. PLoS Biol. 2017;15:e2000784. [cited 2019 Feb18]
   PubMed Web of Science ®Google Scholar
• Ma L, Zhou Y, Luo X, et al. Long non-coding RNA XIST promotes cell growth and invasion through regulating miR-497/MACC1 axis in gastric cancer. Oncotarget. 2017;8:4125–4135.
   PubMedGoogle Scholar
• Chandrasinghe P, Stebbing J, Warusavitarne J. The MACC1-SPON2 axis: a new biomarker and therapeutic target in colorectal cancer. Oncogene. 2017;36:1474–1475.
   PubMed Web of Science ®Google Scholar
• Chae YK, Chang S, Ko T, et al. Epithelial-mesenchymal transition (EMT) signature is inversely associated with T-cell infiltration in non-small cell lung cancer (NSCLC). Sci Rep. 2018;8:2918.
   PubMed Web of Science ®Google Scholar
• Li S, Xu F, Zhang J, et al. Tumor-associated macrophages remodeling EMT and predicting survival in colorectal carcinoma. Oncoimmunology. 2018;7:e1380765.
   PubMed Web of Science ®Google Scholar
• Su S, Liu Q, Chen J, et al. A positive feedback loop between mesenchymal-like cancer cells and macrophages is essential to breast cancer metastasis. Cancer Cell. 2014;25:605–620.
   PubMed Web of Science ®Google Scholar
• Gharagozloo M, Rezaei A, Kalantari H, et al. Decline in peripheral blood NKG2D + CD3 + CD56+ NKT cells in metastatic colorectal cancer patients. Bratisl Lek Listy. 2018;119:6–11.
   PubMed Web of Science ®Google Scholar
• Apithy MJ, Charbonnier A, Desoutter J, et al. Impact of MICA and NKG2D polymorphisms in HLA-fully matched related and unrelated hematopoietic stem cell transplantation. Bone Marrow Transplant. 2018;53:918–922.
   PubMed Web of Science ®Google Scholar
• Ma Y, Gong J, Liu Y, et al. MicroRNA-30c promotes natural killer cell cytotoxicity via up-regulating the expression level of NKG2D. Life Sci. 2016;151:174–181.
   PubMed Web of Science ®Google Scholar
• Espinoza JL, Nguyen VH, Ichimura H, et al. A functional polymorphism in the NKG2D gene modulates NK-cell cytotoxicity and is associated with susceptibility to Human Papilloma Virus-related cancers. Sci Rep. 2016;6:39231.
   PubMed Web of Science ®Google Scholar
• Otegbeye F, Ojo E, Moreton S, et al. Inhibiting TGF-beta signaling preserves the function of highly activated, in vitro expanded natural killer cells in AML and colon cancer models. PLoS One. 2018;13:e0191358.
   PubMed Web of Science ®Google Scholar